Swiss Life Asset Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $76M | Sell |
209,837
-11,622
| -5% | -$3.98M | 0.31% | 62 |
|
|
2026
Q1 | $77.9M | Buy |
221,459
+23,333
| +12% | +$8.32M | 0.38% | 52 |
|
|
2025
Q4 | $64.8M | Sell |
198,126
-73,214
| -27% | -$23.2M | 0.33% | 57 |
|
|
2025
Q3 | $76.6M | Buy |
271,340
+6,082
| +2% | +$1.76M | 0.4% | 47 |
|
|
2025
Q2 | $74.1M | Sell |
265,258
-13,841
| -5% | -$3.92M | 0.44% | 49 |
|
|
2025
Q1 | $87M | Buy |
279,099
+18,375
| +7% | +$5.43M | 0.63% | 29 |
|
|
2024
Q4 | $67.9M | Buy |
260,724
+107,818
| +71% | +$32M | 0.5% | 37 |
|
|
2024
Q3 | $49.2M | Sell |
152,906
-22,967
| -13% | -$7.51M | 0.56% | 31 |
|
|
2024
Q2 | $54.9M | Buy |
175,873
+62,642
| +55% | +$18.4M | 0.65% | 25 |
|
|
2024
Q1 | $32.2M | Sell |
113,231
-16,864
| -13% | -$4.93M | 0.45% | 55 |
|
|
2023
Q4 | $37.5M | Sell |
130,095
-17,274
| -12% | -$4.71M | 0.45% | 36 |
|
|
2023
Q3 | $39.6M | Buy |
147,369
+28,849
| +24% | +$7.2M | 0.61% | 26 |
|
|
2023
Q2 | $26.3M | Sell |
118,520
-1,494
| -1% | -$347K | 0.39% | 42 |
|
|
2023
Q1 | $29M | Sell |
120,014
-20,789
| -15% | -$5.1M | 0.44% | 36 |
|
|
2022
Q4 | $37M | Sell |
140,803
-7,857
| -5% | -$2.11M | 0.62% | 27 |
|
|
2022
Q3 | $33.5M | Buy |
148,660
+21,140
| +17% | +$5.12M | 0.58% | 32 |
|
|
2022
Q2 | $31.1M | Buy |
127,520
+1,318
| +1% | +$323K | 0.5% | 33 |
|
|
2022
Q1 | $30.5M | Sell |
126,202
-5,173
| -4% | -$1.19M | 0.43% | 43 |
|
|
2021
Q4 | $29.6M | Buy |
131,375
+5,259
| +4% | +$1.11M | 0.38% | 52 |
|
|
2021
Q3 | $26.8M | Buy |
126,116
+2,151
| +2% | +$495K | 0.37% | 57 |
|
|
2021
Q2 | $24.3M | Buy |
123,965
+3,216
| +3% | +$791K | 0.25% | 65 |
|
|
2021
Q1 | $30M | Sell |
120,749
-9,723
| -7% | -$2.32M | 0.43% | 45 |
|
|
2020
Q4 | $30M | Sell |
130,472
-99,098
| -43% | -$22.8M | 0.44% | 43 |
|
|
2020
Q3 | $58.3M | Buy |
229,570
+19,469
| +9% | +$4.82M | 0.87% | 20 |
|
|
2020
Q2 | $49.6M | Buy |
210,101
+1,383
| +0.7% | +$316K | 0.8% | 25 |
|
|
2020
Q1 | $42.3M | Buy |
208,718
+26,783
| +15% | +$5.85M | 0.8% | 25 |
|
|
2019
Q4 | $43.9M | Sell |
181,935
-137,171
| -43% | -$30.2M | 0.83% | 26 |
|
|
2019
Q3 | $61.7M | Sell |
319,106
-69,636
| -18% | -$13.4M | 0.81% | 30 |
|
|
2019
Q2 | $71.6M | Buy |
388,742
+33,902
| +10% | +$6.07M | 0.87% | 26 |
|
|
2019
Q1 | $67.4M | Buy |
354,840
+45,230
| +15% | +$8.64M | 0.85% | 27 |
|
|
2018
Q4 | $60.3M | Sell |
309,610
-17,030
| -5% | -$3.32M | 1.23% | 17 |
|
|
2018
Q3 | $67.7M | Buy |
326,640
+16,691
| +5% | +$3.29M | 0.91% | 21 |
|
|
2018
Q2 | $57.2M | Buy |
309,949
+8,273
| +3% | +$1.46M | 0.86% | 22 |
|
|
2018
Q1 | $51.4M | Buy |
301,676
+31,295
| +12% | +$5.74M | 0.9% | 19 |
|
|
2017
Q4 | $47M | Buy |
270,381
+59,494
| +28% | +$10.5M | 1.05% | 19 |
|
|
2017
Q3 | $39.3M | Sell |
210,887
-3,524
| -2% | -$624K | 1.05% | 20 |
|
|
2017
Q2 | $36.9M | Sell |
214,411
-2,774
| -1% | -$451K | 0.95% | 17 |
|
|
2017
Q1 | $35.6M | Buy |
217,185
+35,132
| +19% | +$5.84M | 0.96% | 18 |
|
|
2016
Q4 | $26.6M | Buy |
182,053
+64,723
| +55% | +$9.74M | 0.89% | 23 |
|
|
2016
Q3 | $19.6M | Buy |
117,330
+7,655
| +7% | +$1.29M | 0.67% | 33 |
|
|
2016
Q2 | $16.7M | Hold |
109,675
| – | – | 0.69% | 35 |
|
|
2016
Q1 | $16.4M | Hold |
109,675
| – | – | 0.69% | 29 |
|
|
2015
Q4 | $17.8M | Sell |
109,675
-900
| -0.8% | -$141K | 0.79% | 24 |
|
|
2015
Q3 | $15.3M | Buy |
110,575
+10,241
| +10% | +$1.61M | 0.74% | 27 |
|
|
2015
Q2 | $15.4M | Buy |
100,334
+2,817
| +3% | +$451K | 0.54% | 25 |
|
|
2015
Q1 | $15.6M | Buy |
+97,517
| New | +$15.4M | 0.63% | 23 |
|
Other funds holding AMGN
Swiss Life Asset Management's AMGN Position: Q2 2026 in Review
Swiss Life Asset Management reduced its Amgen (AMGN) stake by 5.2% in Q2 2026, selling an estimated $3.98M and leaving 209,837 shares worth $76M. The position accounts for 0.31% of the portfolio, ranked #62.
Swiss Life Asset Management first reported a position in AMGN in Q1 2015 and has held it in 46 quarters since. The position peaked at $87M in Q1 2025. 2,457 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Swiss Life Asset Management held 209,837 shares of Amgen worth $76M as of Q2 2026.
- Swiss Life Asset Management sold 11,622 Amgen shares in Q2 2026, an estimated $3.98M.
- Amgen made up 0.31% of Swiss Life Asset Management's portfolio in Q2 2026, its #62 holding.
- Swiss Life Asset Management first reported a position in Amgen in Q1 2015 and has held it in 46 quarters since.
- Swiss Life Asset Management's Amgen position peaked at $87M in Q1 2025.
- 2,457 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.